Johnson & Johnson's Peter Fasolo has announced that he will retire from his position as Executive Vice President and Chief Human Resources Officer at the end of 2024.
This follows 16 years of service to the company, working with three CEOs to shape its human capital strategy.
Kristen Mulholland will take his place, who has worked across J&J's Medicine and MedTech sectors, as well as the company's HR unit.
Ms Mulholland will also be appointed to the company's executive board, which will be effective from October 1, 2024.
“Peter has led J&J’s talent strategy for the past 16 years including remarkable leadership through the global pandemic and the separation of our consumer health business,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson.
“Throughout his career, Peter has always led with two principles in the forefront of every decision and recommendation – Our Credo values and a deep responsibility to our employees. He leaves a legacy of strong leaders, deep bench strength and an inclusive, caring and patient-focused culture.”
“I’m pleased to appoint Kristen to this important role where she will apply her deep business acumen, talent expertise and Credo-based approach to advance J&J’s culture and operating model,” continued Mr Duato.
“I’m confident her breadth of experience and strong leadership will ensure Johnson & Johnson’s human capital strategy is poised to deliver the innovative future-ready talent and culture needed to advance healthcare solutions for patients worldwide.”
